Boryung, Kiara Health to supply W8b cancer treatment to Africa
Oct. 19, 2016
[THE INVESTOR] Boryung Pharmaceuticals has signed an agreement with South Africa’s Kiara Health to supply cancer drugs worth 7.8 billion won (US$6.93 million) to 10 African countries, it announced on Oct. 19. The South Korean pharmaceutical company will provide three injectable medicines including AD mycin (Doxorubicin) to South Africa, Namibia, Botswana, Zimbabwe, Uganda, Tanzania, Nigeria, Ethiopia, Rwanda and Kenya for five years. Kiara Health is a leading medical distributor based in Johanne